An Open-label Controlled Trial to Assess the Prophylactic Efficacy of N-Acetylcysteine on Radio-contrast Induced Nephropathy in Patients With Advanced Chronic Kidney Disease Planned to Start Dialysis Therapy
Not Applicable
- Conditions
- Patients with advanced CKD planned to dialysis therapy
- Registration Number
- JPRN-UMIN000000581
- Lead Sponsor
- Department of Nephrology, Rinku General Medical Center Izumisano Municipal Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1)Contraindicated to radiocontrast agent or N-Acetylcysteine 2)Malignancy 3)Congestive heart failure(NYHA III, IV) 4)Acute myocardial infarction, pulmonary embolism and cerebral infarction within 6 months 5)Diastolic blood pressure of 100 mmHg or more
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method